全文获取类型
收费全文 | 5909篇 |
免费 | 356篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 321篇 |
妇产科学 | 138篇 |
基础医学 | 664篇 |
口腔科学 | 90篇 |
临床医学 | 416篇 |
内科学 | 1273篇 |
皮肤病学 | 92篇 |
神经病学 | 329篇 |
特种医学 | 223篇 |
外科学 | 1206篇 |
综合类 | 125篇 |
一般理论 | 3篇 |
预防医学 | 255篇 |
眼科学 | 134篇 |
药学 | 502篇 |
中国医学 | 8篇 |
肿瘤学 | 448篇 |
出版年
2023年 | 48篇 |
2022年 | 72篇 |
2021年 | 180篇 |
2020年 | 90篇 |
2019年 | 177篇 |
2018年 | 198篇 |
2017年 | 125篇 |
2016年 | 139篇 |
2015年 | 141篇 |
2014年 | 237篇 |
2013年 | 239篇 |
2012年 | 381篇 |
2011年 | 409篇 |
2010年 | 199篇 |
2009年 | 178篇 |
2008年 | 305篇 |
2007年 | 242篇 |
2006年 | 254篇 |
2005年 | 246篇 |
2004年 | 240篇 |
2003年 | 203篇 |
2002年 | 185篇 |
2001年 | 127篇 |
2000年 | 141篇 |
1999年 | 148篇 |
1998年 | 38篇 |
1997年 | 48篇 |
1996年 | 41篇 |
1995年 | 31篇 |
1994年 | 26篇 |
1993年 | 30篇 |
1992年 | 99篇 |
1991年 | 103篇 |
1990年 | 74篇 |
1989年 | 88篇 |
1988年 | 72篇 |
1987年 | 73篇 |
1986年 | 70篇 |
1985年 | 87篇 |
1984年 | 45篇 |
1983年 | 40篇 |
1979年 | 25篇 |
1977年 | 22篇 |
1975年 | 22篇 |
1974年 | 34篇 |
1973年 | 38篇 |
1972年 | 27篇 |
1969年 | 24篇 |
1968年 | 27篇 |
1967年 | 22篇 |
排序方式: 共有6279条查询结果,搜索用时 15 毫秒
991.
Eloubeidi MA Varadarajulu S Desai S Wilcox CM 《Journal of gastroenterology and hepatology》2008,23(4):567-570
Background and Aims: Endoscopic ultrasound‐guided fine needle aspiration (EUS‐FNA) is a safe and accurate technique for diagnosing pancreatic cancer. The value of repeat EUS‐FNA in patients with high clinical suspicion for pancreatic cancer after an inconclusive index study is unknown. Our aims were to determine the yield and success of repeat EUS‐FNA and the reasons for failure of initial EUS‐FNA. Methods: This was a retrospective analysis of prospectively collected data in a tertiary University based referral center for pancreatico‐biliary disorders. All patients who underwent more then one EUS‐FNA for evaluation of suspected pancreatic cancer over a five and a half year period were included in this analysis. Results: Of the 547 procedures performed on 517 patients, 24 (4.6%) patients underwent 51 repeat EUS‐FNA procedures. Initial EUS‐FNA was atypical/suspicious in 10 (41.6%), benign in 10 (41.6%), malignant in two (8.3%), and failed/indeterminate in two (8.3%) patients. Eight of 10 (80%) patients with atypical/suspicious findings at initial EUS‐FNA were diagnosed with malignancy on repeat EUS‐FNA. Of the 10 patients with benign findings at initial EUS‐FNA, repeat study diagnosed two (20%) with malignancy and the rest were confirmed benign on long‐term follow up (average 530 days, SD 369 days). Of the two patients with indeterminate findings at initial EUS‐FNA, repeat study diagnosed one patient with malignant disease and the other with benign disease that was confirmed by long‐term follow up. Of the two patients diagnosed with neoplastic disease at initial EUS‐FNA, repeat EUS‐FNA with immunostains downgraded both to chronic pancreatitis. Repeat EUS‐FNA facilitated determination of the true status of disease in 20 of 24 patients (accuracy 84%). Suspected reasons for failed initial EUS‐FNA were: coexisting pancreatitis (n = 10; 42%), technical difficulty due to scope positioning in uncinate lesion/sedation failure (n = 4; 16.7%), difficult cytology (partly cystic, extensive necrosis, well‐differentiated adenocarcinoma) (n = 4; 16.7%), presence of ascites or collaterals (n = 3; 12.5%), pathologist's interobserver variation (n = 2; 8.33%), and unknown reason in one patient. Conclusion: Repeat EUS‐FNA is warranted in patients with high clinical suspicion for pancreatic cancer despite indeterminate or negative findings at initial EUS‐FNA. 相似文献
992.
Colon cancer, the third leading cause of mortality from cancer in the United States, afflicts about 150,000 patients annually. More than 10% of these patients exhibit familial clustering. The most common and well characterized of these familial colon cancer syndromes is hereditary nonpolyposis colon cancer syndrome (Lynch syndrome), which accounts for about 2% to 3% of all cases of colon cancer in the United States. We review the current knowledge of familial cancer syndromes, with an emphasis on Lynch syndrome and familial adenomatous polyposis. 相似文献
993.
Mishra RC Tripathy S Desai KM Quest D Lu Y Akhtar J Gopalakrishnan V 《Hypertension》2008,51(3):791-796
L-serine is a precursor of central neurotransmitters. Its cardiovascular effects are largely unstudied. We compared the in vitro effects of L-serine and acetylcholine in phenylephrine-constricted third-order branches of mesenteric arterioles in the NO synthase inhibitor N(G)-nitro L-arginine methyl ester (L-NAME), pretreated hypertensive rats, and a control group of normotensive male Sprague-Dawley rats. The changes in mean arterial pressure and heart rate evoked by acute intravenous infusion of either L-serine (0.1 to 3.0 mmol/kg) or acetylcholine (0.1 to 10.0 nmol/kg) were determined in anesthetized rats. L-serine evoked concentration-dependent (10 to 200 micromol/L) vasodilatation in endothelium-intact but not in endothelium-denuded vessels. It was abolished by the inclusion of a combination of apamin (SK(Ca) channel inhibitor) and TRAM-34 (IK(Ca) channel inhibitor) or ouabain (Na(+) pump inhibitor) and Ba(2+) (K(ir) channel inhibitor) or when the vessels were constricted by potassium chloride. The maximal response to L-serine was higher in the L-NAME treatment group (control 20% versus L-NAME 40%) in relation to the maximal response to acetylcholine (control 93% versus L-NAME 79%). L-serine evoked a rapid, reversible, dose-dependent fall in mean arterial pressure without increasing heart rate and was more pronounced in L-NAME-treated rats (maximal response: >60 mm Hg) than in the control rats (maximal response: 25 mm Hg). This was inhibited (P<0.01) by apamin+charybdotoxin pretreatment. The in vitro and in vivo data confirm that L-serine promotes vasodilatation in resistance arterioles and evokes a greater fall in mean arterial pressure in NO synthase-inhibited hypertensive rats via activation of apamin and charybdotoxin/TRAM-34-sensitive K(Ca) channels present on the endothelium. 相似文献
994.
Nehilla BJ Bergkvist M Popat KC Desai TA 《International journal of pharmaceutics》2008,360(1-2):107-114
The intent of this work was to synthesize and comprehensively characterize ubiquinone-loaded, surfactant-free biodegradable poly(lactic-co-glycolic acid) (PLGA) nanoparticles in vitro. Surfactant-free, empty and ubiquinone (CoQ10)-loaded biodegradable nanoparticles were synthesized by nanoprecipitation, and the physicochemical properties of these nanoparticles were analyzed with a variety of techniques. Nanoprecipitation consistently yielded individual, sub-200nm, surfactant-free empty and CoQ10-loaded nanoparticles, where the physical and drug encapsulation characteristics were controlled by varying the formulation parameters. CoQ10 release was sustained for 2 weeks but then plateaued before 100% CoQ10 release. A novel, nondestructive purification protocol involving transient sodium dodecyl sulfate (SDS) adsorption to nanoparticles followed by centrifugation and dialysis was developed to yield purified, surfactant-free, CoQ10-loaded nanoparticles. This protocol permitted removal of unencapsulated CoQ10, prevented centrifugation-induced nanoparticle aggregation and preserved the surfactant-free and drug encapsulation properties of the nanoparticles. These CoQ10-loaded nanoparticles are promising as sustained drug delivery devices due to their extended CoQ10 release. Importantly, a surfactant-free nanoprecipitation procedure is presented that in combination with a novel purification step enables the synthesis of individual and purified CoQ10-loaded nanoparticles. 相似文献
995.
The potent general anesthetic etomidate produces its effects by enhancing GABA(A) receptor activation. Its photolabel analog [(3)H]azi-etomidate labels residues within transmembrane domains on alpha and beta subunits: alphaMet236 and betaMet286. We hypothesized that these methionines contribute to etomidate sites formed at alpha-beta subunit interfaces and that increasing side-chain bulk and hydrophobicity at either locus would mimic etomidate binding and block etomidate effects. Channel activity was electrophysiologically quantified in alpha(1)beta(2)gamma(2L) receptors with alpha(1)M236W or beta(2)M286W mutations, in both the absence and the presence of etomidate. Measurements included spontaneous activation, GABA EC(50), etomidate agonist potentiation, etomidate direct activation, and rapid macrocurrent kinetics. Both alpha(1)M236W and beta(2)M286W mutations induced spontaneous channel opening, lowered GABA EC(50), increased maximal GABA efficacy, and slowed current deactivation, mimicking effects of etomidate on alpha(1)beta(2)gamma(2L) channels. These changes were larger with alpha(1)M236W than with beta(2)M286W. Etomidate (3.2 muM) reduced GABA EC(50) much less in alpha(1)M236Wbeta(2)gamma(2L) receptors (2-fold) than in wild type (23-fold). However, etomidate was more potent and efficacious in directly activating alpha(1)M236Wbeta(2)gamma(2L) compared with wild type. In alpha(1)beta(2)M286Wgamma(2L) receptors, etomidate induced neither agonist-potentiation nor direct channel activation. These results support the hypothesis that alpha(1)Met236 and beta(2)Met286 are within etomidate sites that allosterically link to channel gating. Although alpha(1)M236W produced the larger impact on channel gating, beta(2)M286W produced more profound changes in etomidate sensitivity, suggesting a dominant role in drug binding. Furthermore, quantitative mechanistic analysis demonstrated that wild-type and mutant results are consistent with the presence of only one class of etomidate sites mediating both agonist potentiation and direct activation. 相似文献
996.
997.
Laura K. Schnackenberg Lisa Pence Vikrant Vijay Carrie L. Moland Nysia George Zhijun Cao Li‐Rong Yu James C. Fuscoe Richard D. Beger Varsha G. Desai 《Journal of applied toxicology : JAT》2016,36(11):1486-1495
The present study aimed to identify molecular markers of early stages of cardiotoxicity induced by a potent chemotherapeutic agent, doxorubicin (DOX). Male B6C3F1 mice were dosed with 3 mg kg?1 DOX or saline via tail vein weekly for 2, 3, 4, 6 or 8 weeks (cumulative DOX doses of 6, 9, 12, 18 or 24 mg kg?1, respectively) and euthanized a week after the last dose. Mass spectrometry‐based and nuclear magnetic resonance spectrometry‐based metabolic profiling were employed to identify initial biomarkers of cardiotoxicity before myocardial injury and cardiac pathology, which were not noted until after the 18 and 24 mg kg?1 cumulative doses, respectively. After a cumulative dose of 6 mg kg?1, 18 amino acids and four biogenic amines (acetylornithine, kynurenine, putrescine and serotonin) were significantly increased in cardiac tissue; 16 amino acids and two biogenic amines (acetylornithine and hydroxyproline) were significantly altered in plasma. In addition, 16 acylcarnitines were significantly increased in plasma and five were significantly decreased in cardiac tissue compared to saline‐treated controls. Plasma lactate and succinate, involved in the Krebs cycle, were significantly altered after a cumulative dose of 6 mg kg?1. A few metabolites remained altered at higher cumulative DOX doses, which could partly indicate a transition from injury processes at 2 weeks to repair processes with additional injury happening concurrently before myocardial injury at 8 weeks. These altered metabolic profiles in mouse heart and plasma during the initial stages of injury progression due to DOX treatment may suggest these metabolites as candidate early biomarkers of cardiotoxicity. Published 2016. This article is a U.S. Government work and is in the public domain in the USA 相似文献
998.
999.
Desai SV 《The New Zealand dental journal》2007,103(4):101-107
Natural rubber latex (NRL) allergy is a significant clinical problem with potentially life-threatening complications. Oral health care professionals must be able to screen for NRL allergy and refer patients or staff to a specialist for definitive diagnosis. Protocol for its management must be developed and incorporated into daily practice. Practitioners must be able to recognize and treat NRL exposure emergencies. Knowledge of the availability of substitute products and an adequate fresh stock of such products in dental practice can minimise the risk of adverse NRL sensitivity. 相似文献
1000.
J P Barret P Dziewulski S E Wolf M H Desai R J Nichols D N Herndon 《Burns : journal of the International Society for Burn Injuries》1999,25(6):509-513
Bleeding is a major concern during burn wound excision. To evaluate the efficacy of epinephrine to control blood loss, a prospective cohort of 42 pediatric patients were examined. Half of the patients received topical epinephrine to excised wounds and donor sites and subcutaneous epinephrine to scalp donor sites during total burn excision, while the other half did not. Both groups of patients received bovine topical thrombin sprayed at a concentration of 1000 U/ml. Mean blood loss in the epinephrine group was 1090 ml (range 20-4000), with a blood loss of 0.48+/-0.12 ml/cm2 excised, while the control group was 1271 ml (range 40-3750) and 0.51+/-0.15 ml/cm2. Differences in preoperative and postoperative hematocrits were respectively -3.4+/-7.8 and -4.6+/-7.5. The groups were not statistically different in this analysis. Subgroup analysis by age, burn size and time of burn to excision showed no differences. No complications or side effects of the use of the vasopressor solution occurred. In conclusion, no differences in blood loss were found between the groups. The routine use of local epinephrine during total wound excision in combination with topical thrombin in pediatric patients operated within 24 h after the admission may not be necessary. The effect of topical thrombin on blood loss should be analyzed separately. 相似文献